SBFM

Sunshine Biopharma
SBFM

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$7
376% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
AC
Aegis Capital
David Bouchey
0% 1-yr SBFM win rate
8 Oct ‘25 1 month ago